Celgene Corp.
US ˙ NASDAQ ˙ US1510201049
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityCELG / Celgene Corp.
InstitutionGLG Partners LP
ManagerNoam Gottesman
Latest Disclosed Ownership9,290 shares
Latest Disclosed Value $ 970,000
GLG Partners LP reports 40.49% decrease in ownership of CELG / Celgene Corp.

On February 14, 2018 - GLG Partners LP filed a 13F-HR form disclosing ownership of 9,290 shares of Celgene Corp. (US:CELG) valued at $969,504 USD as of December 31, 2017. The entity filed a previous 13F-HR on November 14, 2017 disclosing 15,611 shares of Celgene Corp.. This represents a change in shares of -40.49% during the quarter. The current value of the position is $1,005,550 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2018-02-14 2017-12-31 13F CELGENE COM 151020104 9,290 -6,321 -40.49 970 -57.38 0.0454
2017-11-14 2017-09-30 13F CELGENE COM 151020104 15,611 1,611 11.51 2,276 25.19 0.1206
2017-08-14 2017-06-30 13F CELGENE COM 151020104 14,000 0 0.00 1,818 4.36 0.1006
2017-05-15 2017-03-31 13F CELGENE COM 151020104 14,000 0 0.00 1,742 7.53 0.0814
2017-02-14 2016-12-31 13F CELGENE COM 151020104 14,000 -7,500 -34.88 1,620 -27.90 0.0646
2016-11-14 2016-09-30 13F CELGENE COM 151020104 21,500 -4,850 -18.41 2,247 -13.54 0.0692
2016-08-15 2016-06-30 13F CELGENE COM 151020104 26,350 0 0.00 2,599 -1.44 0.0778
2016-05-16 2016-03-31 13F CELGENE COM 151020104 26,350 -49,750 -65.37 2,637 -71.07 0.0747
2016-02-16 2015-12-31 13F CELGENE COM 151020104 76,100 36,865 93.96 9,114 114.75 0.2898
2015-11-16 2015-09-30 13F CELGENE COM 151020104 39,235 8,901 29.34 4,244 20.88 0.1122
2015-08-14 2015-06-30 13F CELGENE COM 151020104 30,334 -24,583 -44.76 3,511 -44.54 0.0909
2015-05-15 2015-03-31 13F CELGENE COM 151020104 54,917 11,122 25.40 6,331 29.23 0.2111
2015-02-17 2014-12-31 13F CELGENE COM 151020104 43,795 -29,552 -40.29 4,899 -29.53 0.1428
2014-11-14 2014-09-30 13F CELGENE COM 151020104 73,347 28,799 64.65 6,952 81.70 0.1592
2014-08-14 2014-06-30 13F CELGENE COM 151020104 44,548 44,548 3,826 0.0912
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.